Viewing Study NCT06738368

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 5:31 PM

Ignite Modification Date: 2025-12-24 @ 5:31 PM

Study NCT ID: NCT06738368

Status: NOT_YET_RECRUITING

Last Update Posted: 2025-12-22

First Post: 2024-12-12

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

Sponsor: University of Washington

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module